| | |
| 0963 | Protease Inhibitors Enhance Antifungal Activity of MUC7-Derived Peptide in Saliva
G.-X. WEI, University at Buffalo, The State University of New York, USA, and L.A. BOBEK, University at Buffalo, The State University of New York, USA |
| 0964 | Expression of an Actinomyces naeslundii T14V type 1 fimbriae-associated gene
K.P. LEUNG1, C.A. KUCHENTHAL1, G.F. STAMPER1, and J. CISAR2, 1US Army Dental Research Detachment, Great Lakes, IL, USA, 2NIDCR, NIH, Bethesda, MD, USA |
| 0966 | Protective effects of human saliva on murine oral candidiasis
Y. KIYOURA1, S. ABE2, H. YAMAGUCHI2, Y. CHIBA3, and T. NITTA1, 1Ohu University, Koriyama, Fukushima, Japan, 2Teikyo University, Tokyo, Japan, 3Ohu University, Koriyama Fukushima, Japan |
| 0967 | Zinc or EGTA Effects on Histatin Antifungal Activity in Saliva
D.H. HUYNH, M. JEFFERSON, and E. THOMAS, University of Tennessee Health Science Center, Memphis, USA |
| 0968 | Inhibition of C.albicans Adherence to Epithelial Cells by Salivary Antibodies
T. FUKUIZUMI, H. NAGAMATSU, T. KOJO, and H. INOUE, Kyushu Dental College, Kitakyushu, Japan |
| 0969 | Phospholipases of Candida albicans in a Model of Oral Candidosis
J.A.M.S. JAYATILAKE, Oral Biosciences,Faculty of Dentistry,University of Hong Kong, Hong Kong, and L.P. SAMARANAYAKE, Oral Biosciences,Faculty of Dentistry,University of Hong Kong, Hong Kong |
| 0970 | Factors Mediating the Sensitivity of Candidal Biofilms to Nystatin
Y. JIN1, L. SAMARANAYAKE2, Y.H. SAMARANAYAKE3, and H.K. YIP3, 1University of Hong Kong, The Prince Philip Dental Hospital, Hong Kong, 2University of Hong Kong, Hong Kong S.A.R, China, 3University of Hong Kong, Hong Kong |
| 0971 | Phospholipase Enzyme (caPLB1) Expression and Candidal Virulence in HIV Infection
Y.H. SAMARANAYAKE, J.A.M.S. JAYATILAKE, L.P. SAMARANAYAKE, J.Y.Y. YAO, and B.P.K. CHEUNG, University of Hong Kong, Prince Philip Dental Hospital, Hong Kong |
| 0972 | Quantitative Analyses of Candida Adhesion Using Atomic Force Microscopy
G. LUO, G. TANG, and L.P. SAMARANAYAKE, University of Hong Kong, Hong Kong |
| 0973 | Farnesol Responsiveness in Candida albicans Clinical Isolates
J. SÉGUIN, S. DESMEULES, C. MESSIER, M.-C. RIENDEAU, and J. BARBEAU, Université de Montréal, Canada |
| 0974 | Suppression of Candida albicans in Plaque Microcosms by Maunuka Honey
C.H. SISSONS1, S.A. ANDERSON1, and P.C. MOLAN2, 1University of Otago, Wellington School of Medicine and Health Sciences, Wellington, New Zealand, 2University of Waikato, Hamilton, New Zealand |
| 0975 | Oral Candida Carriage in Dry Mouth Patients
T. OHSHIMA, Y. NAKAGAWA, U. YASUNARI, S. NAMIKOSHI, H. WATANABE, K. YAMAMOTO, Y. NOMURA, and N. MAEDA, Tsurumi University, Yokohama, Kanagawa, Japan |
| 0976 | Candida albicans hyphal regulation of beta-defensins in oral epithelial cells
B. JIANG1, J. CHANDRA2, M.A. GHANNOUM2, and A. WEINBERG2, 1Case Western Reserve University, Cleveland, OH, USA, 2Case Western Reserve University, cleveland, OH, USA |
| 0977 | Growth Conditions Affect Candida albicans Interaction with Fibronectin
P.A. SAMANT, J.J. GARY, M.J. PABST, and J.P. BABU, University of Tennessee, College of Dentistry, Memphis, USA |
| 0978 | Candida albicans Polymorphism Affects Interactions with Oral Epithelial Cells
C. VILLAR, H. KASHLEVA, and A. DONGARI-BAGTZOGLOU, University of Connecticut, Farmington, USA |
|